GSK's Linerixibat Accepted for EMA Review for Cholestatic Pruritus in PBC
CompanyDrug

GSK’s Linerixibat Accepted for EMA Review for Cholestatic Pruritus in PBC

Sanofi's Sarclisa Recommended for EU Approval in Newly Diagnosed Multiple Myeloma
CompanyDrug

Sanofi’s Sarclisa Recommended for EU Approval in Newly Diagnosed Multiple Myeloma

Beijing Tightens Price Risk Management for Scarce Medications
Policy / Regulatory

Beijing Tightens Price Risk Management for Scarce Medications

Cloudbreak Pharma's IPO Raises HKD 522M for Ophthalmic Drug Development
CompanyDeals

Cloudbreak Pharma’s IPO Raises HKD 522M for Ophthalmic Drug Development

Formation Bio Licenses Gusacitinib to Sanofi for Novel Indication Study
CompanyDeals

Formation Bio Licenses Gusacitinib to Sanofi for Novel Indication Study

Novo Nordisk's Ozempic Gets Positive CHMP Opinion for Peripheral Artery Disease
CompanyDrug

Novo Nordisk’s Ozempic Gets Positive CHMP Opinion for Peripheral Artery Disease

Illumina to Acquire SomaLogic for $350M to Expand Proteomics Tech Integration
CompanyDeals

Illumina to Acquire SomaLogic for $350M to Expand Proteomics Tech Integration

Denovo Biopharma Inks Licensing Deal With Chuang Yi for DB104 in Taiwan
CompanyDeals

Denovo Biopharma Inks Licensing Deal With Chuang Yi for DB104 in Taiwan

Hengrui Pharmaceuticals Wins NMPA Approval for Six Novel Solid Tumor Drugs
CompanyDrug

Hengrui Pharmaceuticals Wins NMPA Approval for Six Novel Solid Tumor Drugs

Gan & Lee Pharmaceuticals Presents Phase II Results of GZR18 and GZR4 at ADA Scientific Sessions
CompanyDrug

Gan & Lee Pharmaceuticals Presents Phase II Results of GZR18 and GZR4 at ADA Scientific Sessions

EMA Panel Recommends Bio-Thera's Usymro for Autoimmune Diseases
CompanyDrug

EMA Panel Recommends Bio-Thera’s Usymro for Autoimmune Diseases

J&J's Darzalex SC Recommended by CHMP for High-Risk Smoldering Multiple Myeloma
CompanyDrug

J&J’s Darzalex SC Recommended by CHMP for High-Risk Smoldering Multiple Myeloma